Barinthus Biotherapeutics plc (BRNS) reported Loss for full year of -$61.07 million
The company's earnings came in at -$61.07 million, or -$1.55 per share. This compares with -$73.35 million, or -$1.91 per share, last year.
The company's revenue for the period rose 1771.2% to $14.97 million from $0.80 million last year.
Barinthus Biotherapeutics plc earnings at a glance (GAAP) :
-Earnings: -$61.07 Mln. vs. -$73.35 Mln. last year.
-EPS: -$1.55 vs. -$1.91 last year.
-Revenue: $14.97 Mln vs. $0.80 Mln last year.
For comments and feedback: editorial@rttnews.com